Indian regulator clears Biocon, Mylan'... - Breast Cancer India
Indian regulator clears Biocon, Mylan's biosimilar of Roche's Herceptin
Read more about...
6 Replies
•

manish_vkgTeamBCI
good to know

kontakTeamBCI
Yes - more and more companies should come so that the price monopoly will decrease..
Rana which tablet you have been prescribed
• in reply tokontak
hey kontak. though I'm not on HERCEPTIN, , but on Tamoxifen which have so many brand names and its also cheap. I felt good reading this NEWS so I shared it with others.

sumeet_shahAdministrator
This is definitely good news. Biocon is launching it on 16th January and Mylan on 1st Feb. Once both launch the molecule, I will write a post on it with details and what is their pricing.
• in reply tosumeet_shah
Thanks sir!! I'm eagerly waiting for the post :).
Not what you're looking for?
You may also like...
Effects of herceptin therapy
My mother is experiencing some new grievous physical issues after her 2nd herceptin with chemo...
Info and price of herceptin
Hi, my closed one is suffering from liver cancer which originated from breast cancer. Doctor had...
Current cost of Herceptin in India
Hello,
My Mother-in-law is on 4th stage of Breast Cancer and is recommended to take targeted...